Aug 22, 2009 | American Chronicle
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
MISSISSAUGA, ON, Aug. 17 /CNW/ - Vasogen Inc. , today announced that the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market indicating that Vasogen had not regained compliance with Listing Rule 5550 .
Vasogen and to Combine to Create Publicly-traded Specialty...
Vasogen Inc. and IntelliPharmaCeutics announced today that they have entered into a definitive agreement, subject to shareholder and regulatory approvals, whereby Vasogen will combine with IPC under a plan of arrangement and merger to continue as a publicly-traded entity to be called IntelliPharmaCeutics International Ltd.
Also on Topix